Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8232102 Gene delivery

Patent 8232102 was granted and assigned to nanoTherics on July, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jon Dobson0

Christopher D. Batich0

Date of Patent

July 31, 2012

0

Patent Application Number

119121980

Date Filed

April 21, 2006

0

Patent Citations Received

US Patent 11759482 Methods and compositions for treating skeletal muscular dystrophy

US Patent 11872251 Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction

0

US Patent 11660317 Compositions comprising cardiosphere-derived cells for use in cell therapy

0

US Patent 11660355 Engineered extracellular vesicles for enhanced tissue delivery

0

Patent Primary Examiner

0

Patent abstract

The present invention relates to a method of delivery of a therapeutic agent to a target cell the method comprising targeting particles comprising the therapeutic agent to the cell using magnetic means to apply a magnetic force to said particles so as to tend to move said particles towards said magnetic means and at the same time moving said magnetic means.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8232102 Gene delivery

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool